S100A7 and ductal breast carcinoma in situ: Although highly expressed in DCIS and generally down-regulated in invasive breast cancer, the expression of psoriasin/S100A7 in both in-situ and invasive breast cancer is correlated with markers of poor prognosis [3,4] and in invasive carcinoma also with poor clinical outcome [5].